Circulating Tumour Cells Market

Global Circulating Tumor Cells Market by Technology (CTC Enrichment Methods[Positive Enrichment, Negative Enrichment, and Other Technologies], and CTC Detection Methods[Immunocytochemical Technology, Molecular (RNA)-based Technology, Other CTC Detection Methods]), Applications (Multiple Chromosome Abnormalities, RNA Profiling, Protein Expression, Cellular Communication, and Others), Products (Kits & Reagents, Blood Collection Tubes, and Devices or Systems), Tumor Cells Specimens (Blood, Bone Marrow, Other Body Fluids), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecast, 2020-2027

  • Report ID: HC-197
  • Author: Growth Market Reports
  • Rating: 4.6
  • Total Reviews: 6
  • No. Of Pages: 145
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global circulating tumor cells market is anticipated to expand at substantial CAGR during the forecast period, between 2020 and 2027. Adoption of new technology, advancements in biotechnology and bioengineering technology for the detection of diseases, and rising demand for companion diagnostics are driving the growth of the global circulating tumor cells market.

Circulating tumor cells are tumor cells, which have shed from primary tumor and circulate in the body through blood circulation.Circulating tumors are used for the detection of cancer and to analyze the progression of the disease. Tumor markers are used with circulating tumors for the diagnosis of cancer.


Market Trends, Drivers, Restraints, and Opportunities:

  • Rising prevalence of cancer is one of the major reasons for the growth of the circulating tumor cell testing market.
  • Increasing demand for high benefit-cost ratio (BCR) associated with circulating tumor cell testing fuels the market growth.
  • Circulating tumors cells are used for the development of preventive medicines for cancer; therefore, rising research for the development of such medicines is expected to create opportunities in the market.
  • High costs of treatments and medicines are expected to hamper the market.


Scope of the Report:

Attributes Details
Base Year 2019
Historic Data 2017 & 2018
Forecast Period 2020–2027
Regional Scope Asia Pacific, North America, Europe, Latin America, and Middle East & Africa
Report Coverage Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

 
The report on the globalcirculating tumor cells market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.


Circulating tumor cells Market Segment Insights:

The CTC enrichment methods segment is projected to hold a significant share of the market
Based on technology, the circulating tumor cells market can be segmented into CTC enrichment methods and CTC detection methods. The CTC enrichments methods segment is sub-segmented into positive enrichment, negative enrichment, and others.The CTC detection methods segment is further divided into immunocytochemical technology, molecular RNA based technology, and others. The negative enrichment method sub-segment of the CTC enrichments methods segment is projected to grow at a significant pace during the forecast period. Negative enrichment methods are used for the isolation of the circulating tumors. Conversely, the immunocytochemical technology segment is anticipated to expand at a significant CAGR between 2020 and 2027.

The multiple chromosome abnormalities segment to hold significant market share
On the basis of applications, the market can be segregated into multiple chromosome abnormalities, RNA profiling, protein expression, cellular communication, and others.The multiple chromosome segment is projected to constitute a significant share of the market during the forecast period. Rising prevalence of multiple chromosome abnormality syndromes is expected to drive the growth of the segment.

The devices or systems segment is expected to grow at a rapid pace during the forecast period
In the terms of products, the circulating tumor cells products market can be fragmented into kits and reagents, blood collection tubes, and devices or systems. The kits and reagents segment is projected to grow at a significant pace during the forecast period, due tothe availability of a wide range of products. Growing use of devices or systems for the detection of cancer cells is expected to propel the market.

The blood segment to grow during the forecast period
Based on tumor cells specimens, the market can be classified as blood, bone marrow, and other body fluids. The blood segment is expected to hold a significant share of the market during the forecast period. Blood samples are used for the prognosis of diseases.High throughput techniques are used for the detection of genomes in the blood samples, thereby driving the segment.

North America dominates the global market
On the basis of regions, the global circulating tumor cells market can be categorized as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounts for a considerable share of the global market. The US is expected to account for a significant share of the market during the forecast period, owing to the presence of advanced healthcare infrastructure and skilled professionals in the country. Increasing prevalence of cancer in the US is propelling the growth of the market in the region.
 

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Circulating Tumour Cells Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Circulating Tumour Cells Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Circulating Tumour Cells Market - Supply Chain
  4.5. Global Circulating Tumour Cells Market Forecast
     4.5.1. Circulating Tumour Cells Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Circulating Tumour Cells Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Circulating Tumour Cells Market Absolute $ Opportunity
5. Global Circulating Tumour Cells Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Circulating Tumour Cells Market Size and Volume Forecast by Applications
     5.3.1. Multiple Chromosome Abnormalities
     5.3.2. RNA Profiling
     5.3.3. Protein Expression
     5.3.4. Cellular Communication
     5.3.5. Other Applications
     5.3.6.  
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Circulating Tumour Cells Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Circulating Tumour Cells Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Circulating Tumour Cells Demand Share Forecast, 2019-2026
7. North America Circulating Tumour Cells Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Circulating Tumour Cells Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Circulating Tumour Cells Market Size and Volume Forecast by Applications
     7.4.1. Multiple Chromosome Abnormalities
     7.4.2. RNA Profiling
     7.4.3. Protein Expression
     7.4.4. Cellular Communication
     7.4.5. Other Applications
     7.4.6.  
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Circulating Tumour Cells Demand Share Forecast, 2019-2026
8. Latin America Circulating Tumour Cells Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Circulating Tumour Cells Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Circulating Tumour Cells Market Size and Volume Forecast by Applications
     8.4.1. Multiple Chromosome Abnormalities
     8.4.2. RNA Profiling
     8.4.3. Protein Expression
     8.4.4. Cellular Communication
     8.4.5. Other Applications
     8.4.6.  
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Circulating Tumour Cells Demand Share Forecast, 2019-2026
9. Europe Circulating Tumour Cells Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Circulating Tumour Cells Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Circulating Tumour Cells Market Size and Volume Forecast by Applications
     9.4.1. Multiple Chromosome Abnormalities
     9.4.2. RNA Profiling
     9.4.3. Protein Expression
     9.4.4. Cellular Communication
     9.4.5. Other Applications
     9.4.6.  
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Circulating Tumour Cells Demand Share Forecast, 2019-2026
10. Asia Pacific Circulating Tumour Cells Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Circulating Tumour Cells Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Circulating Tumour Cells Market Size and Volume Forecast by Applications
     10.4.1. Multiple Chromosome Abnormalities
     10.4.2. RNA Profiling
     10.4.3. Protein Expression
     10.4.4. Cellular Communication
     10.4.5. Other Applications
     10.4.6.  
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Circulating Tumour Cells Demand Share Forecast, 2019-2026
11. Middle East & Africa Circulating Tumour Cells Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Circulating Tumour Cells Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Circulating Tumour Cells Market Size and Volume Forecast by Applications
     11.4.1. Multiple Chromosome Abnormalities
     11.4.2. RNA Profiling
     11.4.3. Protein Expression
     11.4.4. Cellular Communication
     11.4.5. Other Applications
     11.4.6.  
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Circulating Tumour Cells Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Circulating Tumour Cells Market: Market Share Analysis
  12.2. Circulating Tumour Cells Distributors and Customers
  12.3. Circulating Tumour Cells Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

By Technology

  • CTC Enrichment Methods
    • Positive Enrichment
    • Negative Enrichment
    • Other Technologies
  • CTC Detection Methods
    • Immunocytochemical Technology
    • Molecular (RNA)-based Technology
    • Other CTC Detection Methods
By Applications
  • Multiple Chromosome Abnormalities
  • RNA Profiling
  • Protein Expression
  • Cellular Communication
  • Other Applications
By Products
  • Kits and Reagents
  • Blood Collection Tubes
  • Device or Systems
By Specimens
  • Blood
  • Bone Marrow
  • Other Body Fluids
By Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

Key players in the global circulating tumor cells market includeAviva Biosciences, Advanced Cell Diagnostics Inc., Biocept Inc., LungLife AI Inc., Creatv Micro Tech, Inc., Miltenyi Biotec, Menarini Silicon Biosystems, Precision for Medicine,, and Qiagen NV. They engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence and market share.

Buy Report